E. Brill

Prexasertib, a cell cycle checkpoint kinases 1 and 2 inhibitor, increases in vitro toxicity of PARP inhibition by preventing Rad51 foci formation in BRCA wild type high-grade serous ovarian cancer

J. Nair, Jung-Min Lee, Minshu Yu, 2017, Oncotarget.

Apoptosis is augmented in high-grade serous ovarian cancer by the combined inhibition of Bcl-2/Bcl-xL and PARP

E. Kohn, Jung-Min Lee, T. Yokoyama, 2017, International journal of oncology.

Targeting the PI3K/mTOR Pathway Augments CHK1 Inhibitor–Induced Replication Stress and Antitumor Activity in High-Grade Serous Ovarian Cancer

J. Nair, Jung-Min Lee, Craig J. Thomas, 2020, Cancer Research.